FDA Reverses Proposed Talc-Asbestos Testing Rule for Cosmetics
In a surprising turn of events, the U.S. Food and Drug Administration (FDA) has withdrawn a proposed rule that would have mandated asbestos testing in talc-containing cosmetic products. This rule, initially published on December 27, 2024, was a part of the implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). It would have necessitated standardized testing methods using Polarized Light Microscopy (PLM) and Transmission Electron Microscopy (TEM) to detect the presence of this harmful carcinogen.
Health advocates, who have been advocating for stronger oversight of talc products, are shocked by this withdrawal. Talc products are commonly found in various cosmetics like foundation, blush, mascara, eye shadow, and even some dietary supplements. Dr. Arthur Frank from Drexel University points out that “many talc-containing products do contain asbestos fibers”. Moreover, the International Agency for Research on Cancer classifies talc that may contain asbestos as “probably carcinogenic”.
The FDA has cited “scientific, technical, and legal complexities” as the reasons for this withdrawal. They have expressed their intention to develop a “more comprehensive approach” in the future. In contrast, the European Union is proceeding with its plans to ban talc in cosmetics by 2027, underscoring the international concern about the safety of this ingredient.